Helmut
★★★
avatar
Homepage
Vienna, Austria,
2007-03-21 14:56
(7025 d 09:39 ago)

Posting: # 592
Views: 10,967
 

 FDA: ACPSCP Meeting (HVDs, NTI Drugs) [BE/BA News]

Dear colleagues,

following topics will be discussed at a public meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly Advisory Committee for Pharmaceutical Science) on 02 May 2007:
  1. Receive an update from the Office of Generic Drugs (OGD) on the bioequivalence of highly variable drugs,
  2. receive an update on and discuss general strategies within the OGD pertaining to the bioequivalence of narrow therapeutic index drug products, and
  3. discuss and provide comments on the topic of alcohol-induced dose dumping.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Ohlbe
★★★

France,
2007-04-06 18:38
(7009 d 06:57 ago)

@ Helmut
Posting: # 642
Views: 8,639
 

 FDA: ACPSCP Meeting (HVDs, NTI Drugs)

Dear HS,

The meeting has been cancelled.

See notice in the Federal Register

Regards
Ohlbe
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2007-04-06 18:49
(7009 d 06:47 ago)

@ Ohlbe
Posting: # 644
Views: 8,570
 

 FDA: ACPSCP Meeting cancelled

Dear Ohlbe,

thanks!
We are only waiting for almost 20 years for substantial progress in the case of HVDs (was already a topic at the first Bio-International '89 in Toronto...)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
104 visitors (0 registered, 104 guests [including 20 identified bots]).
Forum time: 01:36 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5